Xibrom and Movement - unpredictable or jerky - a phase IV clinical study of FDA data

Summary:

Movement - unpredictable or jerky is reported only by a few people who take Xibrom.

The phase IV clinical study analyzes which people take Xibrom and have Movement - unpredictable or jerky. It is created by eHealthMe based on reports of 149 people who have side effects while taking Xibrom from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 06, 2022

149 people reported to have side effects when taking Xibrom.
Among them, 2 people (1.34%) have Movement - unpredictable or jerky.

What is Xibrom?

Xibrom has active ingredients of bromfenac sodium. eHealthMe is studying from 160 Xibrom users for its effectiveness, alternative drugs and more.

What is Movement - unpredictable or jerky?

Movement - unpredictable or jerky is found to be associated with 1,008 drugs and 657 conditions by eHealthMe.

Number of Xibrom and Movement - unpredictable or jerky reports submitted per year:

Could Xibrom cause Movement - unpredictable or jerky?

Gender of people who have Movement - unpredictable or jerky when taking Xibrom *:

female: 100 %
male: 0.0 %

Age of people who have Movement - unpredictable or jerky when taking Xibrom *:

Common drugs people take besides Xibrom *:

Prevacid: 2 people, 100.00%
Metoclopramide: 2 people, 100.00%
Enbrel: 1 person, 50.00%
Humulin R: 1 person, 50.00%
Humalog: 1 person, 50.00%
Glucophage: 1 person, 50.00%
Glipizide: 1 person, 50.00%
Folic Acid: 1 person, 50.00%
Fluticasone Propionate: 1 person, 50.00%
Flexeril: 1 person, 50.00%

Common side effects people have besides Movement - unpredictable or jerky *:

Neuropathy Peripheral (surface nerve damage): 2 people, 100.00%
Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 100.00%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 100.00%
Emotional Disorder: 1 person, 50.00%
Diabetes Mellitus Inadequate Control: 1 person, 50.00%
Diabetic Nephropathy (diabetic kidney disease): 1 person, 50.00%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 50.00%
Dizziness: 1 person, 50.00%
Drowsiness: 1 person, 50.00%
Dyslipidaemia (abnormal amount of lipids): 1 person, 50.00%

Common conditions people have *:

Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xibrom and have Movement - unpredictable or jerky?

Check whether Movement - unpredictable or jerky is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Movement - unpredictable or jerky and when was it recovered:

Movement - unpredictable or jerky in Xibrom

Expand to all the drugs that have ingredients of bromfenac sodium:

Movement - unpredictable or jerky and drugs with ingredients of bromfenac sodium

Alternative drugs to, pros and cons of Xibrom:

Xibrom (160 reports)

Movement - unpredictable or jerky treatments and more:

Movement - unpredictable or jerky (2,524 reports)

COVID vaccines that are related to Movement - unpredictable or jerky:

Common drugs associated with Movement - unpredictable or jerky:

Clopra: 238 reports
Metoclopramide: 238 reports

How the study uses the data?

The study uses data from the FDA. It is based on bromfenac sodium (the active ingredients of Xibrom) and Xibrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.